Financial Results BME 1Q2013. Source: BME

- 1 -

April 2013

Business Evolution January – March 2013

Business Performance

First quarter 2013

- 2 -

April 2013


Disclaimer

THIS INFORMATION IS STRICTLY CONFIDENTIAL AND IS BEING FURNISHED TO YOU SOLELY FOR YOUR INFORMATION. IT MAY NOT BE REPRODUCED OR REDISTRIBUTED TO ANY OTHER PERSON, AND IT MAY NOT BE PUBLISHED, IN WHOLE OR IN PART, FOR ANY PURPOSE. BY RECEIVING THIS INFORMATION, YOU BECOME BOUND BY THE ABOVE-REFERRED CONFIDENTIALITY OBLIGATION. FAILURE TO COMPLY WITH SUCH CONFIDENTIALITY OBLIGATION MAY RESULT IN CIVIL, ADMINISTRATIVE OR CRIMINAL LIABILITIES.

NEITHER THIS INFORMATION NOR ANY COPY OF IT MAY BE TAKEN, TRANSMITTED INTO, DISCLOSED OR DISTRIBUTED IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN. THE DISTRIBUTION OF THIS INFORMATION IN OTHER JURISDICTIONS MAY ALSO BE RESTRICTED BY LAW AND PERSONS INTO WHOSE POSSESSION THIS INFORMATION COMES SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY SUCH RESTRICTIONS.

THIS INFORMATION DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER FOR SALE OR SOLICITATION OF ANY OFFER TO BUY ANY SECURITIES NOR SHALL IT OR ANY PART OF IT FORM THE BASIS OF OR BE RELIED ON IN CONNECTION WITH ANY CONTRACT OR COMMITMENT TO PURCHASE SHARES.

THE INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN PROVIDED BY BME.

- 3 -

April 2013


Index

A. Results

B. Business Overview

C. Financials

D. Business Drivers

- 4 -

April 2013


Index

A. Results


C. Financials

D. Business Drivers

- 5 -

April 2013


Results

Net profit

Net profit decrease of 7.1% (+8.6% compared to 4Q12)

- 7.1% (€ Million)

+ 8.6%

35.538.5

31.0 30.433.0

1Q12 2Q12 3Q12 4Q12 1Q13

+ 8.6%

- 6 -

April 2013


Solid operating leverage

Costs Revenues Revenues not linked to volumes Ratio

78%

90%

106% 109% 105% 103%112% 118%

112%

2005 2006 2007 2008 2009 2010 2011 2012 1Q13

- 7 -

April 2013


Key ratios benchmarking• Efficiency • ROE

- BME´s data as of 31/03/2013

- Average peer Group figures are calculated using last results published and not taking account of goodwill impairment charges

Average Peer Group

31.0%

13.6%

BME

34.5%

47.0%

BME Average Peer Group

- 8 -

April 2013


Dividends: Maximizing shareholders´ returns

Pay-out Dividend proposal:

Suplementary Dividend: 0.6 €/share – 10th May

Capital contributions return: 0.23 €/share

Extraordinary Dividend: 0.142 €/share

0.956 0.986

0.40 0.40 0.40 0.40

0.60 0.60 0.60 0.60

1.016 0.9860.60 0.60 0.60 0.60

0.372 0.372 0.372 0.372

2007 2008 2009 2010 2011 2012

First interim Dividend Second interim Dividend Suplementary Dividend Extraordinary Dividend

1.972 1.972Total Dividends /Share

Pay Out 82% 86%

1.9721.9721.972

Pay Out 89% 86% 86% 98%

1.972

0.372 €/share - June

- 9 -

April 2013


Index

A. Results


C. Financials

D. Business Drivers

- 10 -

April 2013


Business Areas

Consolidated Revenues 1Q 2013 - %

EBITDA 1Q 2013 - %

Equity 38.3%

Clearing & Settlement

25.5%

Listing 6.9%

Information 11.1%

Derivatives 9.3%

Fixed Income

2.8%

IT & Consulting

6.1%

Equity 38.9%

Clearing & Settlement

29.7%

Listing 5.3%

Information 12.1%

Derivatives 7.6%

Fixed Income 2.6%

IT & Consulting

3.9%

- 11 -

April 2013


Equity MarketThousands of € 1Q 2013 1Q 2012 %

Revenues 27,931 30,184 -7.5%

Expenses (8,003) (8,215) -2.6%

EBITDA 19,928 21,969 -9.3%

70

46

6166

70

63

71

34

49

70

42

57

68

42

52

28.1

6.712.9

25.715.1 17.6

29.7

6.4

9.028.2

7.611.2 28.2

8.4 12.1

3.9

3.4

4.04.6 4.8

4.1 4.0

2.3

2.52.7

2.3 2.1

3.3

3.5

3.4

1/12 2/12 3/12 4/12 5/12 6/12 7/12 8/12 9/12 10/12 11/12 12/12 1/13 2/13 3/13

177199

154170 162

47.758.5

45.1 47.0 48.7

11.3

13.5

8.87.1

10.2

1Q12 2Q12 3Q12 4Q12 1Q13

Equity (Turnover, volume and shares traded)

Turnover (€ Bill.) Shares (Bill.) Trades (Mill.) Turnover (€ Bill.) Shares (Bill.) Trades (Mill.)

- 12 -

April 2013


Equity Market• Effects of the lifting of short selling ban

Steady recovery in trading volumes

0

5,000

10,000

15,000

20,000

25,000

30,000

35,000

40,000

45,000

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

4.0

4.5

5.0

Nu

mb

er o

f tr

ades

(M

illio

n)

Turnover Number of trades

Tu

rno

ver

(€ M

illio

n)

- 13 -

April 2013


11.5

14.0

10.7 10.6 10.4

1Q12 2Q12 3Q12 4Q12 1Q13

Securities under custody: Volumes (€ Billion)

Clearing and Settlement

Mixed performance: Increase in Equity activity and reduction in Fixed income

Thousands of € 1Q 2013 1Q 2012 %

Revenues 18,606 19,528 -4.7%

Expenses (3,380) (3,460) -2.3%

EBITDA 15,226 16,068 -5.2%

Settlement: Number of trades settled(Million of trades)

1,585 1,584 1,571 1,590 1,593

525 474 498 528 530

1Q12 2Q12 3Q12 4Q12 1Q13

Fixed income nominal reg Equity turnover reg

2,110 2,058 2,069 2,118 2,123

- 14 -

April 2013


108 105100 97 94

3.64.0 4.03.6 3.5

1Q12 2Q12 3Q12 4Q12 1Q13

Suscribers (Thous.) P.Quote (Mill.)

Market Data & Information

Information: Subscribers to primary market sources (Average for the period in thousands of subscribers and millions of accesses per quote)

Lower revenues from primary market sources


Revenues 8,092 8,856 -8.6%

Expenses (1,875) (1,851) 1.3%

EBITDA 6,217 7,005 -11.2%

- 15 -

April 2013


Listing

AIAF: New listings (Billion €)

Commercialpaper

Corporate bonds

MBS ABS Prefered securities

Issuers efforts in deleverage has result in a reduction in Private Fixed Income listings


Revenues 5,036 6,091 -17.3%

Expenses (2,310) (2,315) -0.2%

EBITDA 2,726 3,776 -27.8%

1Q12 2Q12 3Q12 4Q12 1Q13

127.4

45.0

85.1

69.981.6

- 16 -

April 2013


• Companies find in the market the mean to adjust debt and reinforce their balances

Investment flows channeled to the Exchange through capital increases and scrip dividends (€ Billion)

• 1Q13 continued with strong levels of activity in flows channeled to the exchange (+15.3% compared to 1Q12)

• Scrip dividends totalled €2.6 billion in 1Q13 (+74.8% yoy)

• According to data provided by the world Federation Exchange (WFE), total amount of flows channeled throught the exchange places BME as the second european exchange in terms of source of financing for companies and among the five first exchanges worlwideSource: FESE (Federation of European Stock Exchanges)

Listing

6,861

5,125

7,8838,645

7,912

1Q12 2Q12 3Q12 4Q12 1Q13

- 17 -

April 2013


7,088

4,200

9,445

6,704

1Q12 1Q13

1,022

1,238

495 476482

1,278

1Q12 1Q13

Derivatives

(Thousand of contracts)

Increase in revenues as a consequence of activity recovery


Revenues 6,801 5,451 24.8%

Expenses (2,923) (2,913) 0.3%

EBITDA 3,878 2,538 52.8%

Stock derivatives contracts tradedIndex derivatives contracts traded

IBEX 35® Futures MiniIBEX 35® Futures IBEX 35® Options Stock Futures Stock Options

(Thousand of contracts)

- 18 -

April 2013


Fixed income

1Q12 set a demanding comparison base


Revenues 2,078 2,905 -28.5%

Expenses (767) (754) 1.7%

EBITDA 1,311 2,151 -39.1%

AIAF – Turnover (Billion €)

Repo Cash TradesMBS& ABS

Commercial paper

Corporate bonds

Preferred securities

1Q12 2Q12 3Q12 4Q12 1Q13

753

571499

407

742

606

379496

666

340

148

120

75

76

67

379,483315,511

234,387419,409

119,135

1Q12 2Q12 3Q12 4Q12 1Q13

753 742

499

407

571

- 19 -

April 2013


IT & ConsultingThousands of € 1Q 2013 1Q 2012 %

Revenues 4,429 4,102 8.0%

Expenses (2,449) (2,618) -6.5%

EBITDA 1,980 1,484 33.4%

- 20 -

April 2013


Breakdown by business areas

€ Thousand 1Q 2013 1Q 2012 % 1Q 2013 1Q 2012 %

Equity Market 27,931 30,184 -7.5% 19,928 21,969 -9.3%

Clearing & Settlement 18,606 19,528 -4.7% 15,226 16,068 -5.2%

Listing 5,036 6,091 -17.3% 2,726 3,776 -27.8%

Market Data & Information 8,092 8,856 -8.6% 6,217 7,005 -11.2%

Derivatives 6,801 5,451 24.8% 3,878 2,538 52.8%

IT & Consulting 4,429 4,102 8.0% 1,980 1,484 33.4%

Fixed income 2,078 2,905 -28.5% 1,311 2,151 -39.1%

REVENUES EBITDA

- 21 -

April 2013


Index

A. Results


C. Financials

D. Business Drivers

- 22 -

April 2013


Balance sheetas of March, 31th (Thousands of €)

2013 2012

Goodwill 82,190 82,190

Other non-current assets 96,758 86,261

Cash and cash equivalents 299,734 344,800

Non-Group current financial assets 44,111,699 36,890,623

Other current assets 395,476 95,569

Total assets 44,985,857 37,499,443

Owners' Equity 446,987 475,372

External Partners 204 0

Non-current liabilities 22,063 17,783

Current liabilities 44,516,603 37,006,288

Total equity and liabilities 44,985,857 37,499,443

- 23 -

April 2013


P/L


Revenues 73,032 77,386 -5.6%

Expenses (25,161) (25,080) 0.3%

EBITDA 47,871 52,306 -8.5%

EBIT 46,084 50,247 -8.3%

Financial results 846 541 56.4%

EBT 46,817 50,640 -7.5%

Net Profit 32,988 35,513 -7.1%

- 24 -

April 2013


EBITDA 1Q 2013/2012 [€ Mill.] Net Profit 1Q 2013/2012 [€ Mill.]

Comparison with 1Q 2012

Revenues 1Q 2013/2012 Costs 1Q 2013/2012

Margins

[€ Mill.] [€ Mill.]-5.6% + 0.3%

73.077.4

1Q 2013 1Q 2012

25.225.1

1Q 2013 1Q 2012

-8.5% -7.1%

47.9 52.3

1Q 2013 1Q 2012

33.0 35.5

1Q 2013 1Q 2012

- 25 -

April 2013


34.5% 32.4%

1Q13 1Q12

54.6%49.9%

1Q13 1Q12

63.1% 64.9%

1Q13 1Q12

Efficiency & ProfitabilityROE Evolution EBIT/Revenues Ratio Evolution

% ROE % EBIT/Revenues

% Cost/EBIT % Efficiency

Efficiency Ratio EvolutionCost/EBIT Ratio Evolution

31.0% 31.2%

1Q13 1Q12

- 26 -

April 2013


Index

A. Results


C. Financials

D. Business Drivers

- 27 -

April 2013


Business drivers: Highly liquid market • Spanish blue-chips are the most liquid stocks in the EMU

Source: Bloomberg 1) As of 31/03/13

RK1Q13

1

2

3

4

5

6

7

8

9

10

22

27

33

Company Daily avg. 1Q/13

Turnover (€ Biilion)RK

33.5

32.5

31.7

22.5

20.4

20.2

19.9

19.5

19.3

18.8

12.3

10.8

8.9

1

2

3

4

5

6

7

8

9

10

22

27

33

0.54

0.52

0.51

0.36

0.33

0.33

0.32

0.31

0.31

0.30

0.20

0.17

0.14

0.023%

0.011%

0.034%

0.026%

0.018%

0.060%

0.027%

0.010%

0.044%

0.030%

0.008%

0.012%

0.014%

Relative weight at EuroStoxx50 (%)1)

Turnover (€ Biilion)

- 28 -

April 2013


• Distribution by markets of business volume of the IBEX 35® companies (2008 – 2012)

Diversified market

Source: Interim Reports from listed companies obtained from CNMV

Spain EU OCDE Rest

19%

17%

25%

- 29 -

April 2013


Q&A

Financial Results BME 1Q2013. Source: BME

Business

Transcript of Financial Results BME 1Q2013. Source: BME

2013-5-14 FirstResources 1Q2013 Financial Announcement

Rajiv Gandhi College of Engineering and TechnologyBME BME ECE ECE BME ECE ECE EEE BME ECE EEE BME BME ECE 10. TNQ (Dec'2016 ) 11. MBIT WIRELESS (Jan'2017) DESIGN OF During floods roads,

BME Growth

BME Welding

Womensnewsletter 1q2013

1Q2013 Dongwon Financial Statement

BME írásbeli

BME MOLECULAR BIOLOGY EXPERIMENT PCR & SEEDING · 2017-09-02 · bme molecular biology experiment pcr & seeding skku bme 3rdgrade, 2ndsemester

BME rmr-Jahresauftakt 2020, mit BME Hanau und DFK

A BME TANULMÁNYI ÉS VIZSGASZABÁLYZATA (BME TVSZ) 2007 · BME TVSZ, elfogadta a Szenátus 2011. június 27-én. 1 BUDAPESTI MŰSZAKI ÉS GAZDASÁGTUDOMÁNYI EGYETEM A BME TANULMÁNYI

BME - hajim.rochester.edu

Tissue Bme

1Q2013 Results Presentation - Concha y Toro · 2018-04-01 · 1Q2013 Results Presentation Jun 12, 2013 . 2 2 / 2 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 France Italy Spain USA

ACADEMIC AFFAIRS COUNCIL - sdbor.eduBiomedical Engineering seminar 3 BME 798 Master’s thesis 12 BME 798 Master’s thesis 12 BME Electives 3 BME electives 3 . Existing Curriculum:

Bme Military

1Q2013 Results Presentation · 2020. 8. 24. · 5 5 / 5 Income Statement (million Ch$) 1Q2013 1Q2012 Change Million. Ch Million. Ch % Operating Results Sales revenues 91,081 88,857

Szállítmányozás BME

BME nyelvvizsga

AL SEGMENTO DE BME GROWTH DE BME MTF EQUITY

China Stock Market Recap - 1Q2013 (CapitalVue)